CClinicalTrials.gg
Status unknownNCT04038606SEINIORUpdated Jul 31, 2019

SEINIOR:Quality of Life and Breast Cancer in Older Women

An interventional study of Determination of acceptance and / or rejection of mastectomy in Breast Cancer, sponsored by Central Hospital Saint Quentin. Status unknown at 1 site in France. Open to female participants aged 75 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-07-31.

Sponsored by Central Hospital Saint Quentin · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Mar 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
174
Allocation
Non-randomized
Ages
75 Years to 100 Years
Sex
Female
01

Study summary

Background :

Breast cancer is a disease that occurs primarily in elderly women: 54057 of breast cancer occurred on women in 2008, 15.2% were between 75 and 84 years and 5.4% were over 85 years. Elderly women cancers care exposes to several problems: the opportunity for screening, knowing that mammography is not recommended after 75 years old, and the level of treatment depending on the background and the existence of weaknesses. It should determine whether patients are in adequate physiological condition to tolerate classical and "complete" treatment or conversely in a precarious state with advanced fragility, justifying only lightened and adapted symptomatic treatment.

Purpose :

The purpose of this research theme is to assess the quality of life of elderly patients who underwent mastectomy for breast cancer. The objectives are:

  • Assess the determinants of acceptance and / or rejection of mastectomy based on personal background (level of fragility, self-image) and linked to cancer
  • Assess the quality of life, 6 months later, of women who underwent or not mastectomy, and appreciate the determinants

Abstract :

The total mastectomy allow, oncologically, a more valid treatment than a lumpectomy, in many cases of women suffering from a breast cancer, but its relevance and acceptability are poorly known. Some think that an elderly woman, postmenopausal, is less concerned with her aesthetics and feminine attributes, which would allow her to accept easily the mastectomy.

The research hypothesis is that the acceptability of mastectomy is not good in elderly women

Read the detailed description

Primary outcome:

Better detection of comorbidity and geriatric syndromes in vulnerable patients Better detection of a degradation of the quality of life at D0 (at diagnosis)

Secondary outcomes:

Better support for quality of life and psychological support after mastectomy (revaluation to 6 months) Integration of patients in the geriatric sector and implementation of regular monitoring Study design: prospective, multicenter

02

Conditions studied

  • Breast Cancer

Browse trials for

03

Who can participate

Ages eligible
75 Years to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  1. Elderly patients about or over 75 years
  2. Female
  3. Patients in whom a diagnosis of breast cancer with surgical indication for mastectomy with or without lymph node dissection is discussed
  4. Ability to understand and give freely consent
  5. Informed consent signed
  6. Patient affiliated to the social security or entitled

Exclusion criteria

Exclusion Criteria:

  1. Patients under 75 years
  2. Male
  3. Patients under legal protection
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
174 participants (estimated)

Study arms

  • Active comparator
    acceptance of mastectomy

    Assess the determinants of acceptance of mastectomy based on personal background,Measured by questionnaires: self-image (Rosenberg),personal background (level of fragility, self-image),quality of life SF-36, QLQC30,pain (BPI-SF) and Big Five Inventory.

    Other: Determination of acceptance and / or rejection of mastectomy

  • Experimental
    rejection of mastectomy

    Assess the determinants of rejection of mastectomy based on personal background, Measured by questionnaires: self-image (Rosenberg),personal background (level of fragility, self-image),quality of life SF-36, QLQC30,pain (BPI-SF) and Big Five Inventory.

    Other: Determination of acceptance and / or rejection of mastectomy

Interventions

  • OtherDetermination of acceptance and / or rejection of mastectomy

    Blood exams,Participants completed a questionnaire translated in French language : Rosenberg,SF-36, QLQC30, Big Five Inventory,BPI-SF.:-)

05

What researchers measure

Primary outcomes

  1. Evaluation of quality of life change by SF-36 (The Short Form Health Survey) between baseline and six months

    the 36-Item Short Form Health Survey (SF-36). SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting and are now widely utilized monitoring and assessment of care outcomes in adult patients. a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability

    Time frame: Baseline and 6 months

Secondary outcomes

  1. QLQ-C30 (Global Health Status)

    Quality of life (QoL or QOL) is the perceived quality of an individual's daily life, that is, an assessment of their well-being or lack thereof. This includes all emotional, social and physical aspects of the individual's life;All of the scales and single-item measures range in score from 0 to 100.

    Time frame: Baseline and 6 months

  2. Psychological profile

    Big Five Inventory (BFI),personality inventory for research settings, minimum = 45 points and maximum scores = 180 points .

    Time frame: Baseline and 6 months

06

Study locations

1 of 1 sites recruiting
  • Centre Hospitalier de Saint-Quentin;
    Saint-Quentin, Aisne 02100, France
    • ATTIER Dr Jadwiga, PI · Contact
    Recruiting
07

References and documents

Individual participant data

Plan to share: No — Participants completed a questionnaire that included the test sociodemographic characteristics and a number of standardized validated instruments translated in French language designed to assess for quality of life and psychological profile. Participants will undergo blood test, electrocardiogram, blood pressure monitoring, geriatric standard evaluation.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04038606
Lead sponsor
Central Hospital Saint Quentin
Responsible party
Sponsor
First posted
Jul 31, 2019
Start date
Dec 15, 2016
Primary completion
Dec 15, 2020 (estimated)
Completion
Dec 15, 2020 (estimated)
Last update
Jul 31, 2019

Study contacts

ATTIER-ZMUDKA Dr Jadwiga, IC
Contact
J.ATTIER@ch-stquentin.fr
00333 23 06 72 16
BOULANOUAR M Abdelkrim, CRA
Contact
AK.BOULANOUAR@ch-stquentin.fr
0033323067861
ATTIER-ZMUDKA Dr Jadwiga, PI
principal investigator · Saint Quentin Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion